Health News Articles

Excerpts of key news articles on

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.

Some Marketplace reports about vitamins and supplements published in November contained incorrect information, CBC has learned. Last fall, Marketplace commissioned lab testing for samples of fish oil, vitamin C and protein powder supplements to see if consumers are actually getting what they pay for. Based on those test results, Marketplace reported that Emergen-C and two protein powders: GNC Lean Shake 25 and Cytosport Muscle Milk failed to live up to label claims. However, subsequent re-testing of the samples has found that the lab results and analysis provided to Marketplace were incorrect, and that there is no evidence of problems with those products. The original lab tests were performed by an independent lab in Michigan, which is ISO-17025 accredited, registered with the U.S. Food and Drug Administration, and used by the supplement industry. The lab was recommended by Neil Thanedar, co-founder and CEO of LabDoor, a company that has products tested and makes those results public to help guide consumers about vitamins and supplements. CBC re-tested some of the products at other independent, accredited labs. None of them found problems with the samples. While Thanedar admits some of the lab results he provided to Marketplace were flawed, he was still unable to explain how the mistakes were made.

Note: Definitely something fishy going on here. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

When does Big Pharma profiting become profiteering? This issue was the subject last month of a Senate Finance Committee investigation of pricing practices of Gilead Sciences Inc., a leading provider of hepatitis C medications. After examining 20,000 pages of internal company documents, looking at Medicaid data and interviewing health care experts, the authors concluded that the Foster City drugmaker “pursued a calculated scheme for pricing and marketing its hepatitis C drug based on one goal: maximizing revenue regardless of the human consequences.” With the hepatitis C virus affecting about 3 million people in the United States, the impact of Gilead’s pricing strategy is real, measurable - and devastating. With a 12-week course of Gilead’s Harvoni priced at nearly $100,000, taxpayer-funded Medicare Part D spent $4.6 billion on hepatitis C alone in the first half of 2015. When insurers refuse to pay for treatment, all but the wealthy are left at risk for cirrhosis, liver cancer and death. While anticipating record profits of $30 billion in 2015, Gilead virtually eliminated its medication assistance program. More than 90 percent of hepatitis C patients can achieve a cure with as little as one pill a day. But to realistically address this epidemic at current pricing levels would bankrupt our health care system. Pharmaceutical innovation holds great promise for the future of our health care system. But not if none of us can afford it.

Note: For more along these lines, see concise summaries of deeply revealing news articles about big pharma profiteering. Then read an in-depth essay titled "The Truth About Drug Companies" by acclaimed author Dr. Marcia Angell.

Abdel Gawad Ellabbad knows exactly how he was infected with hepatitis C. As a schoolboy in this Nile Delta rice-farming village, his class marched to the local clinic every month for injections against schistosomiasis, a parasitic disease spread by water snails. Six million Egyptians were infected with hepatitis C by unsterile needles during the country’s decades-long fight against schistosomiasis. The virus spread insidiously; today, at least 10 percent of Egyptians, nearly nine million people, are chronically infected, the highest rate in the world. But a grand experiment unfolding across the country may change all that. Pharmaceutical companies are testing ... a complicated deal to sell hepatitis drugs at a fraction of their usual cost. If [successful] the arrangement in Egypt may serve as a blueprint not just for curing hepatitis around the world, but also for providing other cutting-edge medicines to citizens in poor countries who could never afford them. The experiment here is about a year old and, while still fragile, appears to be headed for success. Mr. Ellabbad, for one, was finally cured of hepatitis this spring. An air-conditioning repairman, he took a three-month regimen that included sofosbuvir, first of the new generation of miracle drugs. The pills would have cost more than $84,000 in the United States. He got them free from the Egyptian government, which paid about $900. “Before, I felt like I was dying,” he said. “Now I feel like I’ve never felt before. Like I’m 35 again.”

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

The world’s biggest animal “cloning factory” is due to open in China, producing one million calves a year, sniffer dogs and even genetic copies of the family pet. The center may cause alarm in Europe, where the cloning of animals for farming was banned in September due to animal welfare considerations. But Xu Xiaochun, chairman of Chinese biotechnology company BoyaLife that is backing the facility, dismissed such concerns. Interest in agricultural biotechnology has been rapidly increasing in China, where [beef prices] are said to have tripled from 2000 to 2013. Mr Xu said his new facility will clone racehorses and a handful of dogs for people with “emotional ties” to their pets, but its main focus was producing cattle. However, he appeared to be more excited about its ability to churn out sniffer dogs. “The dog has to be smart and obedient, strong, sensitive," he said. The factory, which will include a 15,000 square metre laboratory, an animal centre, a gene bank and an exhibition hall ... is due to open in the first half of next year. BoyaLife will operate the facility with its South Korean partner, Sooam Biotech, that runs a centre that can clone dogs for customers willing to pay $100,000 (Ł66,000), and has already produced more than 550 puppies. The new facility will initially produce 100,000 cattle embryos a year, eventually increasing to one million.

Note: For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

The American Medical Association on Tuesday called for a ban on direct-to-consumer ads for prescription drugs and implantable medical devices, saying they contribute to rising costs and patients' demands for inappropriate treatment. Delegates at the influential group's policy-making meeting in Atlanta voted to adopt that as official policy as part of an AMA effort to make prescription drugs more affordable. It means AMA will lobby for a ban. "Today's vote in support of an advertising ban reflects concerns among physicians about the negative impact of commercially driven promotions and the role that marketing costs play in fueling escalating drug prices," said Dr. Patrice Harris, an AMA board member. According to data cited in an AMA news release, ad dollars spent by drugmakers have risen to $4.5 billion in the last two years, a 30 percent increase. Other data show prices on prescription drugs have climbed nearly 5 percent this year, Harris said in the news release. She also raised concern that advertising spurs use of newer brand-name drugs when other possibly lower-cost options might be just as good. "Direct-to-consumer advertising also inflates demand for new and more expensive drugs, even when these drugs may not be appropriate." The pharmaceutical industry opposes the AMA's stance.

Note: For more along these lines, see concise summaries of deeply revealing big pharma profiteering news articles from reliable major media sources. Then read an in-depth essay titled "The Truth About Drug Companies" by acclaimed author Dr. Marcia Angell.

Turing Pharmaceuticals chief executive Martin Shkreli found himself in the middle of a media firestorm last month as he adamantly defended his company's 4,000 percent drug price hike. Daraprim, which treats a life-threatening infection in patients with HIV/AIDS and other immune problems, was increased to $750 a pill, a move resoundingly decried. Now, another company will offer a Daraprim alternative, at just $1 a pill. It's not an exact replica of Daraprim. San Diego-based Imprimis Pharmaceuticals announced Thursday that it is selling pills containing a "customizable compounded formulation" of pyrimethamine and leucovorin, both ingredients in Daraprim. The Food and Drug Administration doesn't approve compounded drugs, such as this one offered by Imprimis. Typically, compounded drugs are prescribed to patients who can't take FDA-approved drugs, such as for those who are allergic to an inactive ingredient. Compounded drugs are no stranger to controversy; a compounding pharmacy was at the heart of a deadly meningitis outbreak in 2012 that killed 64 people and sickened more than 600. Federal legislators subsequently tightened regulations over such companies. And compounded drugs can be very pricey, too. But it appears the Daraprim alternative compound was not born out of a physical inability to use Daraprim, but a financial one.

Note: Read more about Turing Pharmaceuticals' outrageous Daraprim price-hike. Those in charge of the compounding pharmacy mentioned above were charged with homicide, but when a meningitis outbreak killed 11 children in an illegal Nigerian drug trial conducted by Pfizer, no one at Pfizer was charged with a crime. For more along these lines, see concise summaries of deeply revealing news articles about big pharma corruption.

No industry has aligned itself more closely with the breast cancer movement than the cosmetics industry. Yet while they prominently claim to care about women with breast cancer, their pink ribbon products all too often actually increase risk of the disease. Look Good Feel Better is a ... program run by the Personal Care Products Council (PCPC), the largest national trade group for the cosmetics industry, and the American Cancer Society (ACS), the nation’s largest cancer charity. They hold free workshops that give beauty tips and complimentary makeup kits to women in cancer treatment. Member companies of the [PCPC] donate cosmetic products for the kits given to cancer patients. The American Cancer Society administers the program nationwide. Many of the Look Good Feel Better kits contain ... carcinogens and hormone disruptors. These chemicals ... increase breast cancer risk, [and] interfere with breast cancer treatment. Most breast cancers are hormone-driven and common treatments target the body’s hormonal system. Some hormone disruptors – including methylparaben, which is in concealer and face wipes the ACS is giving to cancer patients – have been shown in a lab to interfere with Tamoxifen, a common hormonal breast cancer treatment. While the European Union has banned 1,300 chemicals from use in cosmetics, the United States has banned fewer than one dozen. The Personal Care Products Council spends millions of dollars lobbying against cosmetic safety regulations.

Note: Read about another example of egregious "pinkwashing" by a fracking company. And watch a promising new documentary on suppressed cancer cures. For more, see concise summaries of deeply revealing corporate corruption news articles, or learn about the promising cancer research too often suppressed in mainstream media.

Quebec-based Valeant Pharmaceutical's price hikes of drugs long off patent has raised the ire of U.S. legislators and frustrated Canadian physicians. Democrats on the House of Representatives committee on oversight and government reform sent a letter Monday to the committee's Republican chairman seeking a subpoena that would force Valeant to turn over documents tied to the U.S. price hikes of two heart drugs. In the U.S., the price of Isuprel or Isoprenaline increased 2,500 per cent and Nitropress went up 1,700 per cent in three years, as the drug changed hands. Valeant purchased the rights to both heart drugs from Marathon Pharmaceuticals in February. As huge overnight drug price hikes becomes an election issue in the U.S., some doctors in Canada struggle to get other prices rolled back. In late 2013, Valeant Canada announced that as of January 2014, the price of a one-month supply of Syprine would match the U.S. price of roughly $13,244, or about 13 times higher than the previous price. The medication makes the difference between a full and productive life or a downward course of increasing liver and neurological disease. For physicians, the price increase put them in the position of having to tell patients their disease can be managed or cured but at an out-of-pocket price of $200,000 a year for the rest of their lives.

Note: For more along these lines, see concise summaries of deeply revealing news articles about big pharma profiteering from reliable major media sources.

Cancer patients need to be prepared for serious side effects from chemotherapy, and hospitalization is one that happens much more often in the real world than in drug trials, according to a new study. Researchers found that people with advanced lung cancer receiving chemotherapy in real-world settings were almost eight times more likely to be hospitalized during treatment than those participating in clinical trials. What's more, very few clinical trials even report how often participants are hospitalized during the research, the study authors found. "Clinical trials should be routinely reporting their hospitalization rates so we know what to expect," said senior author Dr. Monika Krzyzanowska, a medical oncologist at the Princess Margaret Cancer Center in Toronto, Canada. Krzyzanowska and her colleagues write in JAMA Oncology that the number of times a person goes to the hospital with treatment complications is important to the patient and to the hospital. The researchers suggest several possible explanations for the differences in hospitalization rates. First, the patients in highly selective clinical trials are different from real-world patients. In this study, people receiving chemotherapy in real-world settings were also older, on average, than those in clinical trials.

Note: While big pharma profits from hiding the negative effects of their drugs, there is some promising cancer research underway, some of which is being suppressed to keep the cash cow flowing for big pharma.

Pediatrician Carla Nelson ... waited for the ambulance plane to take the infant from Waimea, on the island of Kauai, to the main children’s hospital in Honolulu. It was the fourth [severe heart malformation] she had seen in three years. There have been at least nine in five years, she says, shaking her head. That’s more than 10 times the national rate. Corn that’s been genetically modified to resist pesticides [is] a major cash crop on four of [Hawaii's] six main islands. In Kauai, chemical companies Dow, BASF, Syngenta and DuPont spray 17 times more pesticide per acre than on ordinary cornfields in the US mainland. About a fourth of the total are called Restricted Use Pesticides because of their harmfulness. Just in Kauai, 18 tons – mostly atrazine, paraquat (both banned in Europe) and chlorpyrifos – were applied in 2012. The World Health Organization this year announced that glyphosate, sold as Roundup, the most common of the non-restricted herbicides, is “probably carcinogenic in humans”. When the spraying is underway ... residents complain of stinging eyes, headaches and vomiting. At these times, many crowd the waiting rooms of the town’s main hospital, which was run until recently by Dow AgroSciences’ former chief lobbyist in Honolulu. The chemical companies that grow the corn ... refuse to disclose with any precision which chemicals they use, where and in what amounts, but they insist the pesticides are safe. Today, about 90% of industrial GMO corn grown in the US was originally developed in Hawaii.

Note: For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

DuPont: “one of the most successful and sustained industrial enterprises in the world,” as its corporate website puts it. Perhaps no product is as responsible for its dominance as Teflon. For more than 60 years C8 was an essential ingredient of Teflon. As part of a 2005 settlement over contamination around a West Virginia plant, a team of three scientists ... were charged with determining if and how the chemical affects people. The science panel found that C8 was “more likely than not” linked to ulcerative colitis - as well as to high cholesterol; pregnancy-induced hypertension; thyroid disease; testicular cancer; and kidney cancer. The scientists’ findings, published in more than three dozen peer-reviewed articles, were striking, because the chemical’s effects were so widespread throughout the body and because even very low exposure levels were associated with health effects. DuPont scientists had closely studied the chemical for decades and through their own research knew about some of the dangers it posed. Yet rather than inform workers, people living near the plant, the general public, or government agencies responsible for regulating chemicals, DuPont repeatedly kept its knowledge secret. Another revelation about C8 makes all of this more disturbing: This deadly chemical that DuPont continued to use well after it knew it was linked to health problems is now practically everywhere. A man-made compound that didn’t exist a century ago, C8 is in the blood of 99.7 percent of Americans.

Note: For more along these lines, see concise summaries of deeply revealing corporate corruption news articles from reliable major media sources.

His body ravaged by chemotherapy treatments, retired radio engineer John Kanzius spent months in his basement in 2003 cobbling together a makeshift tumor-killing machine. Kanzius had no medical background. He had been a ham radio operator and the owner of a television and radio station company. But he had leukemia, and he did not want to die. He did not know it then, but the John Kanzius's Noninvasive Radiowave Cancer Device ... would eventually make the pages of respected medical journals and attract the support of leading cancer researchers. Dr. Steven A. Curley, an oncologist ... launched Kanzius’s research into the national spotlight and devoted his career to the project. Curley had treated many cancer patients, but [grew] particularly close with Kanzius. In 2009, Kanzius died at 64 from pneumonia while undergoing chemotherapy. Many thought the Kanzius machine would die with him. But this May, Curley filed protocols with the Italian Ministry of Health to test the radio wave machine on humans diagnosed with pancreatic and liver cancer. Researchers from the University of Pittsburgh, the MD Anderson Cancer Center and Rice University tested the technology [on] human cancer cells in petri dishes, as well as into tumors in mice, rats, rabbits and pigs. Using the Kanzius machine, they were able to heat [injected] nanoparticles and, as a result, kill all those cancerous cells [while surrounding healthy areas remained intact]. Results were published in the oncology medical journal Cancer, as well as Nano Research.

Note: Learn more about promising cancer treatments that are emerging and why these are frequently overlooked. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Jeff Bradstreet, the controversial autism doctor who authorities say committed suicide on June 19 following a federal raid of his offices ... was closely involved with a European company that provided the drug targeted in the search. On June 19, the day of Bradstreet’s death, a European news report described the deaths of five people at a Swiss clinic run by the company, First Immune. The condition that led these people to the clinic remains unclear, as is what caused their deaths, but each patient reportedly paid 5,000 euros per week (about $5,400 US) for treatment. The First Immune Facebook page ... includes a post by a page administrator about the death of Bradstreet that claims: "Dr Bradstreet has been under attack by big pharma for his success during all his professional life so there is no way he would have committed a suicide for just another attack. He was murdered; the FDA were clearly involved, and the other suspect is the MMR vaccine co-orporations, who work with the FDA." Rumors of a murder conspiracy continue to buzz around Bradstreet’s death, and family members have used money from a fundraiser to hire private investigators to look into it.

Note: For other informative articles on the mysterious deaths of alternative health doctors who had developed possible cures for cancer and autism, see this webpage and this one.

Hydraulic fracturing uses a host of highly toxic chemicals that could be contaminating drinking water supplies, wildlife and crops, according to a report released Thursday by a California science panel. The long-awaited final assessment from the California Council on Science and Technology said that because of data gaps and inadequate state testing, overwhelmed regulatory agencies do not have a complete picture of what oil companies are doing. The risks and hazards associated with about two-thirds of the additives used in fracking are not clear, and the toxicity of more than half, the report concluded, remains “uninvestigated, unmeasured and unknown. Basic information about how these chemicals would move through the environment does not exist.” Seth Shonkoff, lead author on the public health sections of the report, said he was surprised to learn during his research that recycled wastewater from oil fields was being used on crops. “We've got to know what to test for ... to know that what we are putting onto the crops is safe,” he said. “Until we have that data, I don't know how we can assure farmers and consumers that their food is safe.” Among the findings of the report: Oil operations in federal waters offshore are discharging wastewater directly into the ocean, against EPA regulations, more than half the produced water from fracked wells is disposed of in unlined pits, [and] about one-third of the oil field wastewater pits in the Central Valley are operating without proper permits.

Note: For more along these lines, read this Los Angeles Times article about how fracking poisons drinking water, and see concise summaries of deeply revealing corporate corruption news articles from reliable major media sources.

The increased use of mammograms to screen for breast cancer has subjected more women to invasive medical treatments but has not saved lives, a new study says. After reviewing cancer registry records from 547 counties across the United States, researchers concluded that the screening tests aren’t working as hoped. Instead of preventing deaths by uncovering breast tumors at an early, more curable stage, screening mammograms have mainly found small tumors that would have been harmless if left alone ... researchers reported Monday in the journal JAMA Internal Medicine. Ideally, the counties with more widespread screening would see a payoff in the form of lower rates of breast cancer deaths. Instead, the researchers found “no evident correlation between the extent of screening and 10-year breast cancer mortality,” they wrote. The results are sure to be troubling to those who have faith in the idea that if mammograms are good, more mammograms must be better. If that were the case, the researchers should have found lower breast cancer mortality rates in counties where screening was more widespread, according to a commentary that accompanied the study. “Sadly, we are left in a conundrum,” the commentary authors wrote. “Women will increasingly approach their physicians with questions and concerns about overdiagnosis, and we have no clear answers to provide.”

Note: For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

A report by the Environmental Protection Agency (EPA) last month found that hydraulic fracturing for oil and gas can lead, and has led, to the contamination of drinking water. It was the first time the federal government had admitted such a link. But Gretchen Goldman, a lead analyst at the Center for Science and Democracy at the Union for Concerned Scientists, told the Guardian that the EPA’s study – which is now open for comment – was nothing “more than a literature review” and called for the industry to be required to divulge greater data. Goldman says the EPA backed down from its initial promise to undertake prospective studies, which would have involved following a well site and testing its waters before, during and after fracking activities had begun. Such a study would have shed objective light on the fracking process and pushed scientific knowledge forward, she says. Even when companies were forced to share information through state regulations, they were still allowed to withhold ... the identity and mixture of chemicals that are injected into the ground through wells, together with water, at high intensity to fracture underground rocks and release oil or gas. In 2005 lobbying efforts by the oil and gas industry proved successful, with hydraulic fracturing activities exempted from certain sections of the Safe Drinking Water Act, including permit application.

Note: For more along these lines, read this Los Angeles Times article about how fracking poisons drinking water, and see concise summaries of deeply revealing corporate corruption news articles from reliable major media sources.

Two former Merck & Co Inc scientists accusing the drugmaker of falsifying tests of its exclusive mumps vaccine said in a court filing on Monday that Merck is refusing to respond to questions about the efficacy of the vaccine. Attorneys ... who represent the scientists asked U.S. Magistrate Judge Lynne Sitarski of the Eastern District of Pennsylvania to compel Merck to respond to their discovery request, which asks the company to give the efficacy of the vaccine as a percentage. Instead of answering the question, the letter said, Merck has been consistently evasive ... saying it cannot run a new clinical trial to determine the current efficacy, and providing only data from 50 years ago. The two scientists, Stephen Krahling and Joan Wlochowski, filed their whistleblower lawsuit in 2010 claiming Merck, the only company licensed by the Food and Drug Administration to sell a mumps vaccine in the United States, skewed tests of the vaccine by adding animal antibodies to blood samples. As a result, they said, Merck was able to produce test results showing that the vaccine was 95 percent effective, even though more accurate tests would have shown a lower success rate. The plaintiffs said these false results kept competitors from trying to produce their own mumps vaccines, since they were unable to match the effectiveness Merck claimed.

Note: For more, read this excellent mercola.com article revealing how a single vaccine can bring in $6 billion in revenue to one company. Read in a CNN report that all 40 Harvard students who recently came down with the mumps had been vaccinated against the disease. For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.

The city council of Berkeley, California, voted Tuesday night to pass a cellphone "right to know" law requiring health warnings with the purchase of a cellphone. When it goes into effect this summer it will be first safety ordinance of its kind in the country. Cellphone retailers will be required to include a city-prepared notice along with the purchase of a cellphone, informing consumers of the minimum separation distance a cellphone should be held from the body. The Federal Communication Commission recommends keeping your phone 5 to 25 millimeters away, depending on the model, to limit radio frequency (RF) exposure to safe levels. "If you carry or use your phone in a pants or shirt pocket or tucked into a bra when the phone is ON and connected to a wireless network, you may exceed the federal guidelines for exposure to RF [radio frequency] radiation," the Berkeley safety notice reads. "This potential risk is greater for children." Lawmakers in at least six states have also considered warnings to address cellphone radiation concerns. The Berkeley proposal seeks to address concerns that even as cellphones become ubiquitous in our lives, many people remain unaware of basic safety recommendations. An April 30th survey funded by the California Brain Tumor Association (CABTA) found that 70 percent of Berkeley adults did not know about the FCC's minimum separation distance.

Note: The American Academy of Pediatrics says that mobile phone radiation is more dangerous for children than adults, and has been petitioning the FCC to modify safety regulations accordingly. For more, read concise summaries of revealing news articles on this and other important health topics.

L.A. County health officials investigate and confirm an infection outbreak inside one of the county's hospitals once or twice a month. The public rarely finds out which hospital is involved, how many patients were stricken or whether any died. The secrecy surrounding hospital outbreaks runs counter to the push toward more public disclosure in healthcare. In recent years, consumers have benefited from data comparing some health outcomes by hospital, the fees hospitals charge for various procedures and the payments doctors receive from drug and device manufacturers. Keeping outbreaks confidential is a common practice of federal, state and local health investigators across the country. The rationale: It encourages hospitals to be open and quickly report suspected surges of infections. The secrecy can prevent hospitals from learning from one another's mistakes. More than six years ago, a lethal bacteria struck two hospitals in Florida, killing 15 patients. The case was nearly identical to the recent outbreaks at UCLA and Cedars-Sinai medical centers. In each case, a hard-to-clean medical scope transferred the same superbug from patient to patient. Since that 2008 Florida outbreak, investigators have tied the same scopes to scores of patient infections in other states. Most of the outbreaks were not disclosed until months or years later, often only when doctors wrote about them in medical journals.

Note: For more along these lines, see concise summaries of deeply revealing news articles about healthcare cover-ups from reliable major media sources.

Many medical "facts" are simply not true. By definition, being "overweight" must be bad for your health – or we wouldn't call it overweight. But we do not define overweight as being the weight above which you are damaging your health; it has an exact definition. To be overweight means having a BMI of between 25 and 30. In 2009, a German group did a painstaking meta-analysis of all studies on overweight and obesity that they could find. As with most other researchers, they found that being overweight was good for you. Of course, they didn't phrase it in this way. They said: "The prevailing notion that overweight increases morbidity and mortality, as compared to so-called normal weight, is in need of further specification." In need of further specification? An interesting phrase, but one that hints at the terrible problems researchers have when their findings fail to match prevailing dogma; if the prevailing consensus is "if your BMI is between 25 and 29, it is damaging your health and you should lose weight", then you challenge this at your peril. Despite the fact that study after study has demonstrated quite clearly that "overweight" people live the longest, no one can bring themselves to say: "Sorry, we were wrong. A BMI between 25 and 29 is the healthiest weight of all. For those of you between 20 and 25, I say, eat more, become healthier." Who would dare say such a thing? Not anyone with tenure at a leading university, that's for sure.

Note: Don't miss the entire article to see how scientists severely manipulate the results of their data when it does not fit established norms. For more along these lines, see the excellent, reliable resources provided in our Health Information Center and concise summaries of deeply revealing news articles about corruption in science.

Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.